Answers are grounded in this paper and cite their sources.
Thalassemia is the most prevalent type of inherited anaemia globally. The most prevailing type of chronic haemolytic anaemia in Egypt is beta thalassemia, around 85.1%. Treatment of thalassemia includes blood transfusions, iron chelating agents, folic acid (Vit B9) and splenectomy. Regular transfusion protocol should only be initiated if the patient suffers from one of the following: hemoglobin level of ⩾7 g/dl couldn’t be reached or growth impairment or progressive enlargement in spleen size. Splenectomy is needed when blood transfusions surpass 200–250 ml/kg/year of PRBC. Patients on regular PRBC transfusions are vulnerable to the following risks: haemolytic reactions, transmission of infection and iron over load. The aims of the current study was the assessment of the prevalence of blood transfusion episodes among thalassemia patients and evaluation of the relationship between the blood transfusion (regarding frequency and type of transfusion) and sociodemographic factors, clinical and laboratory findings. A cross sectional study was conducted. The data was collected from the medical records of 73 thalassemia children patients at Sporting Hospital, Alexandria. The current study showed that splenectomy had a significant effect on the frequency of blood transfusions (X2=9.15, p=0.027). Moreover, we found a significant effect of median ferritin concentration on frequency of blood transfusion after performing kruskal Wallis test (H=17.55, P= 0.007*). After a splenectomy, the interval between blood infusions doubles. In conclusion, the present study reported that a splenectomy reduced the frequency of blood transfusions, Conducting further studies with a considerable sample size in the future will confirm our results.
No takes yet. Share an insight, caveat, or question.
Hassan et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: